Beryl Drugs Ltd Q1FY22 net profit at Rs. 33.95 lakhs

Beryl Drugs Ltd. has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) - QoQ Comparison

The company has reported total income of Rs.4.64 crores during the period ended June 30, 2021 as compared to Rs.5.67 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.0.3395 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.0.1172 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.0.67 for the period ended June 30, 2021 as compared to Rs.0.23 for the period ended March 31, 2021.

Financials	Q1 FY2021-22	Q4 FY20-21	% Change
Total Income	₹ 4.64 crs	₹ 5.67 crs	-18.17%
Net Profit	₹ 0.3395 crs	₹ 0.1172 crs	189.68%
EPS	₹ 0.67	₹ 0.23	191.3%

Financial Results (Q1 FY 2021-22) - YoY Comparison

The company has reported total income of Rs.4.64 crores during the period ended June 30, 2021 as compared to Rs.2.70 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.0.3395 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.(0.196) crores for the period ended June 30, 2020.

The company has reported EPS of Rs.0.67 for the period ended June 30, 2021 as compared to Rs.(0.39) for the period ended June 30, 2020.

Financials	Q1 FY2021-22	Q1 FY2020-21	% Change
Total Income	₹ 4.64 crs	₹ 2.70 crs	71.85%
Net Profit	₹ 0.3395 crs	₹ (0.196) crs	273.21%
EPS	₹ 0.67	₹ (0.39)	271.79%

Shares of Beryl Drugs Ltd. was last trading in BSE at Rs. 11 as compared to the previous close of Rs. 10.09. The total number of shares traded during the day was 15270 in over 70 trades.

The stock hit an intraday high of Rs. 11 and intraday low of 9.21. The net turnover during the day was Rs. 160736.

Source : Equity Bulls

Keywords